NPAT fell 12.1% on 4.6% revenue growth as cost inflation overwhelmed pricing

Operating working capital absorbed only $0.4m this year, below the historical average build of about $1.0m in the supplied baseline; that provided a small favourable swing but is not the source of the earnings decline. Operating cash flow still slipped 5.0% to $33.0m. Capex of $72.1m kept pre-lease free cash flow at -$39.0m. Gross borrowings rose 70.2% to $131.2m and net debt climbed to $129.2m from $75.7m to fund the infrastructure programme. Final dividend was 4.7 cps and the full-year payout was 7.5 cps, unchanged versus FY21.

Revenue grew 4.6% while container volumes fell 7.9%, so reported revenue growth came from price and mix rather than throughput. Management attributes the drag to inflationary cost increases and capability investment, which dropped ROE to 5.2% from 6.5% and pulled PBT growth (-12.9%) and revenue growth (4.6%) to the lower edge of Annolyse's historical baseline (means of 1.3% and 8.0% respectively).

Leverage has stepped up materially to fund infrastructure. Gross borrowings rose to $131.2m from $77.1m and net debt nearly doubled to $129.2m. Capex at $72.1m (62.9% of revenue) remained well in excess of operating cash flow, which means the balance-sheet cushion that existed at FY21 is now substantially smaller, and the share of returns sensitive to volume recovery has increased.

The dividend is now stretched relative to earnings. The 7.5 cps full-year dividend equates to a 75.0% NPAT payout, and pre-lease free cash flow remained -$39.0m (-191.2% of NPAT). The dividend continues to be funded from debt and balance-sheet capacity rather than internally generated cash, so its durability depends on the FY23 earnings rebound landing.

The interim shape supports a recovery read: HY22 contributed only 44.3% of full-year revenue and 44.0% of full-year NPAT, so H2 ran materially stronger ($63.8m revenue and $11.4m NPAT versus $50.7m and $9.0m in H1). The release describes first-half disruption (Omicron, weather, supply chain) stabilising into H2, which is consistent with the volume recovery underpinning guidance but does not by itself validate the magnitude.

The effective tax rate of 26.2% sits within the company's historical range (24.9–28.3%) and is broadly in line with the prior 27.2%, so the 12.9% PBT decline and the 12.1% NPAT decline carry the same operating signal. NPAT margin (17.8%) and PBT margin (24.2%) remain within the supplied historical range, so the result is a normal-range margin year delivered on weaker volumes and higher costs, not a structural break.

Cash quality is weaker than the headline operating cash flow figure suggests. The $0.4m working-capital release was small but below the pattern of $1.0m builds in the supplied baseline, so it should not be extrapolated. More importantly, capex of $72.1m turned $33.0m of operating cash flow into -$39.0m of pre-lease free cash flow, which is at the lower edge of the supplied historical range. Underlying NPAT of $18.6m sits below reported NPAT of $20.4m, suggesting non-recurring items flattered the reported figure, but the supplied materials do not detail the bridge.

This briefing cannot assess whether the FY23 underlying operating result guidance is achievable, because the supplied materials do not disclose forward volume bookings, contracted pricing, or detailed cost-base assumptions.